Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer

NCT00209703 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: l-Leucovorin
DRUG: 5-Fluorouracil

Sponsor

Hokkaido Gastrointestinal Cancer Study Group